Iron-based Binder Safe and Effective in PD

A study conducted with 84 PD patients compared sucroferric oxyhydroxide (n=56) to sevelamer (n=28). After a year, both groups had serum phosphate levels within the target range. The iron-based binder required fewer pills per day and resulted in fewer adverse events. Read the abstract.

Read the abstract » | (added 11/13/2017)

Tags: Chronic Kidney Disease, Hemodialysis, Peritoneal Dialysis; Phosphate Binder, Sevelamer Carbonate, Sucroferric Oxyhydroxide

Related Journal Articles

Chronic Kidney Disease
Peritoneal Dialysis; Phosphate Binder
Sevelamer Carbonate
Sucroferric Oxyhydroxide